Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 201 - 250 out of 1,343

Document Document Title
WO/2002/094791A1
This invention provides compounds of Formula I, their N-oxides and agriculturally suitable salts wherein A and B are independently O or S; J is an optionally substituted 5- or 6-memebered nonaromatic heterocyclic ring; K is taken togethe...  
WO/2002/092656A1
The invention relates to a novel method for producing aliphatic polyisocyanates having an uretdione, isocyanurate and iminooxadiazindione structure, isocyanates thus produced and the use thereof for producing polyurethane lacquers and co...  
WO/2002/092658A1
The invention relates to a novel method for producing polyisocyanates, the products produced therefrom and the use thereof.  
WO/2002/085838A1
The present invention relaters to copper-catalyzed carbon-heteroatom and carbon-carbon bond-forming methods. In certain embodiments, the present invention relates to copper-catalyzed methods of forming a carbon-nitrogen bond between the ...  
WO/2002/074792A1
(Beauveria) sp. FO-6979 (FERM BP-6681), which belongs to the genus Beauveria and is capable of producing FO-6979-M0, -M1, -M2, -M3 and -M4 substances, is cultured in a medium to thereby accumulate the FO-6979-M0, -M1, -M2, -M3 and -M4 su...  
WO/2002/074296A1
Preventives and/or remedies for solid cancer which contain as the active ingredient hydroxamic acid derivatives represented by the following general formula (I): wherein each symbol is as defined in the description; non-toxic salts there...  
WO2002044187A3
This invention provides antioxidant cyclic salen-metal compounds, compositions of such antioxidant cyclic salen-metal compounds having superoxide activity, catalase activity and/or peroxidase activity and methods of using such antioxidan...  
WO/2002/068586A2
With the help of X-ray structural analyses of drug-resistant HIV proteases and molecular modeling, a new type of inhibitor with a small P3 residue has been developed. These inhibitors are effective against HIV and its drug-resistant muta...  
WO/2002/066048A1
The invention relates to the use of crystal modification (I) of a cyclic depsipeptide of formula (I) for producing medicaments, particularly for combating endoparasites.  
WO2001081325A3
The present invention discloses novel macrocyclic compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprisin...  
WO2002024709A3
Compounds of formula (I), wherein R0 is C1-C4alkyl; n0 is 0 or from 1 to 8; X is oxygen or sulfur; and Q is a group Q1, Q2, Q3, Q4 or Q5, wherein R1 is hydrogen, fluorine, chlorine, bromine or methyl; R2 is hydrogen, C1-C4alkyl, C1-C4hal...  
WO/2002/047762A1
Compounds of Formula I where R¿5?, R¿6a?, each X, L, Cy and Lp are as defined in the specification, are tryptase inhibitors useful as anti-inflammatory agents.  
WO/2002/046167A1
The present invention relates to compounds of the formula I wherein 1) Y is a bridge containing bridging heteroatoms and to their medicinal use; 2) As serotonin 1 (5-HT¿1?) receptor ligands, particularly in psychotherapeutic agents.  
WO/2002/044187A2
This invention provides antioxidant cyclic salen-metal compounds, compositions of such antioxidant cyclic salen-metal compounds having superoxide activity, catalase activity and/or peroxidase activity and methods of using such antioxidan...  
WO2002002090A3
The present invention is directed to hydrazino compounds that functions as inhibitors of copper-containing amine oxidases commonly known as semicarbazidesensitive amine oxidases (SSAO), including the human SSAO known as Vascular Adhesion...  
WO2002002541A3
The present invention is directed to 1,3,4-oxadiazine compounds that function as inhibitors of copper-containg amine oxidases commonly known as semicarbazide-sensitive amine oxidases (SSAO), including the human SSAO known as Vascular Adh...  
WO/2002/028845A1
This invention relates to 3/thioxo/[1,2,4]-oxadiazinan-5-one derivatives of formula: (I), wherein R is alkyl, alkenyl, or alkynyl; R¿1? and R¿2? are each independently hydrogen, alkyl, or aryl; and Ar is phenyl, indanyl, benzhydryl, or...  
WO/2002/026724A1
A compound having general formula (I) and methods of using such compounds for the treatment of diseases and pharmaceutical composition comprising such compounds. The compounds are Neurokinin 1 (NK¿1?) receptor antagonists and are useful...  
WO/2002/024709A2
Compounds of formula (I), wherein R¿0? is C¿1?-C¿4?alkyl; n¿0? is 0 or from 1 to 8; X is oxygen or sulfur; and Q is a group Q1, Q2, Q3, Q4 or Q5, wherein R¿1? is hydrogen, fluorine, chlorine, bromine or methyl; R¿2? is hydrogen, C...  
WO/2002/024704A1
Compounds of formula (I), in which R¿0? is C¿1?-C¿4?alkyl; n¿0? is O or from 1 to 8; X and Y independently of one another are oxygen or sulphur, and Q is a group Q1, Q2, Q3, Q4, Q4 or Q5 where R¿1? is hydrogen, fluorine, chlorine, b...  
WO/2002/020531A2
The invention relates to a method for producing anellated tetrahydro-[1H]-triazoles of formula I wherein the variables R?a¿, Z, Z?1¿, X, W, n and Q have the designations cited in patent claim 1, by cyclising compounds of general formul...  
WO/2002/012207A1
Cyclic oxyguanidine compounds, including compounds of Formulae (I and II), wherein R?1¿, R?3¿-R?6¿, R?21¿-R?26¿, L, Y, Z, and A are set forth in the specification, as well as hydrates, solvates or pharmaceutically acceptable salts t...  
WO/2002/004432A1
According to the invention, 2-alkyl-3-aryl- or -heteroaryloxaziridines can be produced particularly advantageously by oxidising suitable N-alkyl-aryl- or -heteroarylaldimines with an aromatic percarboxylic acid or its salt in the presenc...  
WO/2002/002541A2
The present invention is directed to 1,3,4-oxadiazine compounds that function as inhibitors of copper-containg amine oxidases commonly known as semicarbazide-sensitive amine oxidases (SSAO), including the human SSAO known as Vascular Adh...  
WO/2002/002090A2
The present invention is directed to hydrazino compounds that functions as inhibitors of copper-containing amine oxidases commonly known as semicarbazidesensitive amine oxidases (SSAO), including the human SSAO known as Vascular Adhesion...  
WO/2001/096305A1
Compounds of formula (I) where R¿5?, R¿6a?, each X, L, Cy and Lp are as defined in the specification, are tryptase inhibitors useful as antiinflammatory agents.  
WO/2001/081325A2
The present invention discloses novel macrocyclic compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprisin...  
WO/2001/077089A1
A compound having the general formula (I) and methods of using such compounds for the treatment of diseases and pharmaceutical composition comprising such compounds.  
WO/2001/072696A1
Compounds of Formula (I), and their N-oxides and agriculturally suitable salts, are disclosed which are useful as arthropodicides wherein A is H; E is H or C¿1?-C¿3? alkyl; or A and E can be taken together to form -CH¿2?-, -CH¿2?CH¿...  
WO/2001/070674A1
The invention refers to novel propenecarboxylic acid amidoxime derivatives furthermore N-oxides and/or geometrical isomers and/or optical isomers and/or pharmaceutically suitable acid addition salts and/or quaternary derivatives thereof....  
WO2001007029A3  
WO/2001/044238A1
The invention relates to novel pyrazolyl benzyl ethers of general formula (I), a method for producing the same and the use thereof for combating harmful organisms.  
WO/2001/044226A1
Compounds of formula (I) where R¿5?, R¿6a?, each X, L, Cy and Lp are as defined in the specification, are tryptase inhibitors useful as antiinflammatory agents.  
WO/2001/036399A1
The invention relates to azadioxacycloalkenes of general formula (I), in which R?1¿, R?2¿, R?3¿, R?4¿, X, n and the bridging unit W have the meanings given in claim 1. The invention furthermore relates to agents for the treatment of ...  
WO1999002514A3
The present invention relates to compounds of formula (V).  
WO/2001/025222A1
The invention relates to a method for producing 3-alkyl-N-nitro-4H-1,3,5-oxadiazine-4-imines; whereby a) nitric acid is neutralised using an alkyl amine R-NH¿2? in an aqueous solution at a temperature of between - 10 and + 50 °C and th...  
WO/2001/025235A1
Compounds of formula (I) modulate voltage-gated sodium channels and are useful as local anesthetics  
WO/2001/025234A1
This invention is directed to novel anesthetic compounds, preferably of formula (Ia), pharmaceutical composition containing these compounds, methods of use and methods for preparing these compounds.  
WO/2001/023067A1
Compositions and methods for selectively binding metal ions from source solutions are disclosed. The compositions include 1) polyamide-containing ligands covalently bonded to a particulate solid support, and 2) polyamide-containing polym...  
WO/2001/021583A1
Hydroxamic acid derivatives represented by general formula (I), nontoxic salts thereof or prodrugs of the same (wherein each symbol is as defined in the description). Because of inhibiting the production of IL-6, the compounds of the gen...  
WO2000063195A8
The current invention discloses novel heterocyclic amino carbonyl derivatives useful as nitric oxide synthase inhibitors  
WO/2001/014346A1
The present invention is directed to a macrocyclic compounds of formula (I), wherein Q, X, R¿1? and R¿5? are as defined herein. Compounds of the invention are useful for therapeutic and prophylactic treatment of bacterial infection in ...  
WO/2001/007029A2
A method for the treatment of cancer and pain in an animal subject is disclosed, comprising administering to said animal in need of such treatment an effective amount of a compound of formula (I), wherein R?1¿-R?6¿ are defined herein. ...  
WO/2001/000601A1
The invention relates to the area of erythropoiesis, in particular to 4-(2-oxodihydrooxadiazinylphenyl)amides of general formula (I), to methods for producing them and to their use as medicaments, preferably for preventing and/or treatin...  
WO/2001/000600A1
The invention relates to N-substituted perhydro-2, 3-diazine of formula (I), wherein the variables Z, R, m and R?A¿ correspond to the definitions given in claim 1. The invention also relates to a method for the production of N-substitut...  
WO/2001/000602A1
The invention relates to substituted ureas of general formula (Ia) and (Ib), wherein variables X, Z, m, R and R?A¿ have the meaning cited in claim 1 and Q represents one of radicals Q1 to Q6: (Q-1), (Q-2), (Q-3), (Q-4), (Q-5), (Q-6), wh...  
WO/2000/076985A1
The invention relates to cyclo-imino depsipeptides of formula (I), especially 24-membered cyclo-imino depsipeptides. The invention also relates to methods for their preparation and to their utilization in controlling endoparasites.  
WO2000034252A3
Processes for the preparation of Cryptophycins of the formula (II), wherein G is (C1-C12) alkyl, (C2-C12) alkenyl, (C2-C12) alkynyl, or Ar; R<1> is halogen and R<2> is OH or glycinate ester; or R<1> or R<2> may be taken together to form ...  
WO2000034253A3
A process for preparing a compound of the formula (I) wherein G is (C1-C12) alkyl, (C2-C12) alkenyl, (C2-C12) alkynyl, or Ar; Ar is an aromatic or heteroaromatic group or a substituted aromatic or heteroaromatic group; R<3> is (C1-C6) al...  
WO/2000/063195A1
The current invention discloses novel heterocyclic amino carbonyl derivatives useful as nitric oxide synthase inhibitors  

Matches 201 - 250 out of 1,343